Industries > Pharma > In-Vitro Diagnostics World Market 2018-2028

In-Vitro Diagnostics World Market 2018-2028

Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing,Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay

PUBLISHED: 11 September 2018
PAGES: 263
PRODUCT CODE: PHA0330
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0330 Categories: , Tags: , , , ,

The revenue of the in-vitro diagnostics market in 2017 was estimated at $63bn and was dominated by the Point of Care Testing Segment. The Molecular Diagnostics segment will be the fastest growing segment in the first-half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 263-page report you will receive 107 tables and 81 figures– all unavailable elsewhere.

The 263-page report provides clear detailed insight into the in-vitro diagnostics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

In-Vitro Diagnostics market forecasts from 2018-2028

• This report breaks down the revenue forecast for the main submarkets by Type:
Point of care
• Clinical chemistry
• Immunochemistry
• Haematology
• Microbiology
• Molecular Diagnostics
• Flow Cytometry
• Others

• The Point of Care Diagnostic submarket is further segmented into:
• Blood Glucose Testing
• Infectious Disease Testing
• Rapid Coagulation Testing
• Cholesterol Testing
• Pregnancy Testing

• The Clinical Chemistry submarket is further segmented into:
• Basic Metabolic Panel
• Electrolyte Panel
• Liver Profile
• Lipid Profile
• Thyroid Function Test

• The Immunochemistry submarket is further segmented into:
• ELISA
• Immuno-PCR
• Rapid Test
• Western Blot
• Enzyme linked Immunospot Assay

• This report breaks down the revenue forecast for the main submarkets by Application:
• Infectious Diseases
• Diabetes
• Cardiology
• Autoimmune Diseases
• Renal Diseases
• Pharmacogenomics
• HIV/AIDS
• Other Applications

In-Vitro Diagnostics World Market 2018-2028

• This report breaks down the revenue forecast for the main submarkets by Products & Services:
• Analyzers
• Reagents
• Software & Services

• This report breaks down the revenue forecast for the main submarkets by End-User:
• Lab Testing
• Hospital Testing
• University Testing
• Home Care Testing

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• Americas: US, Canada, Mexico, Brazil, Rest of Americas
• Europe: UK, Germany, France, Spain, Italy, Russia, Rest of Europe
• Asia: India, China, Japan, Rest of Asia
• RoW

Each regional and national market is further segmented by type.

• Our study includes SWOT analysis and STEP analysis of the in-vitro diagnostics market.

• Our study discusses the selected leading companies that are the major players in the in-vitro diagnostics market:
• Abbott Diagnostics
• Agilent Technologies
• Becton, Dickinson and Company (BD)
• BioMerieux
• Bio-Rad
• Danaher Corporation
• DiaSorin Diagnostics s.p.a
• Roche Diagnostics
• Siemens Diagnostics
• Sysmex Corporation

Visiongain’s study is intended for anyone requiring commercial analyses for the in-vitro diagnostics market. You find data, trends and predictions.

Buy our report today In-Vitro Diagnostics World Market 2018-2028: Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing, Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for In-Vitro Diagnostics World Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for In-Vitro Diagnostics World Market 2018-2028


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category